Bookbuilding IPO | ₹48 Cr | Listed at NSE SME | Wed, May 17, 2023 - Fri, May 19, 2023
Remus Pharmaceuticals IPO IPO subscription status. Full data available on IPOMatrix.com.
| Category | QIB | NII | Retail | Total | ||
|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor Investor | Total QIB | ||||
| Allocation (No. of shares) | 3,68,500 | |||||
| Allotment price (₹) | 1,229 | |||||
| No. of applications | 50,122 | |||||
| No. of shares applied | 1,56,77,800 | |||||
|
🔒 Preview Limited Full data is available exclusively on IPOMatrix.com — your premium IPO research platform. 🗝️ Login to View All Records → |
||||||
| Amount collected (₹ Cr.) | 1,926.80 Cr | |||||
| No. of times subscribed | 42.54 | |||||
| No. of shares allotted | 3,68,500 | |||||
| Amount allotted (₹ Cr.) | 45.29 Cr | |||||
| No. of allottees | 1,714 | |||||
Remus Pharmaceuticals IPO is a public issue of 0.04 Cr equity shares. The issue offers 0.01 Cr shares to retail investors, 0.02 Cr shares to qualified institutional buyers, and 55,300.00 shares to non-institutional investors.
| Category | Shares Offered | Amt (₹ Cr.) | Size (%) |
|---|---|---|---|
| Market Maker | 19,500 | 2.40 | 5.03% |
| QIB | 1,84,200 | 22.64 | 47.47% |
| Anchor | 1,10,500 | 13.58 | 28.48% |
| QIB (Ex Anchor) | 73,700 | 9.06 | 18.99% |
| NII | 55,300 | 6.80 | 14.25% |
| Retail | 1,29,000 | 15.85 | 33.25% |
| Total | 3,88,000 | 47.69 | 100% |
A total of 1,10,500 shares at a price of Rs 1,229 per share will be allotted to the anchor investors.
| Bid Date | May 16, 2023 |
| Price | ₹1,229.00 |
| % of QIBs | 59.99% |
| Shares Locked (30 Days) | 55,250 |
| Shares Locked (90 Days) | 55,250 |
| # | Anchor | Group Entity | Shares Allotted | Amt (₹ cr.) | % Allocated | % Allotment of Issue |
|---|---|---|---|---|---|---|
| 1 | CHHATTISGARH INVESTMENTS LTD. | CHHATTISGARH INVESTMENTS | 1,01,700 | 12.50 | 92.04 | 26.21 |
| 2 | NAV CAPITAL VCC | NAV CAPITAL | 8,800 | 1.08 | 7.96 | 2.27 |
📊 Historic report - IPOs Anchor Investors Investment & Performance
The Remus Pharmaceuticals IPO is subscribed 42.54x.
Category-wise data available on IPOMatrix.com
Login to view QIB, NII, Retail and all category details
| Category | Subscription (times) |
|---|---|
| Total | 42.54x |
Remus Pharmaceuticals IPO total subscription is 42.54x.
Category-wise data available on IPOMatrix.com
Login to view QIB, NII, Retail and all category details
An investor can apply in Remus Pharmaceuticals IPO online via bank (using ASBA) or the broker (using UPI). The Remus Pharmaceuticals IPO shares are offered online only.
The Remus Pharmaceuticals IPO is subscribed 42.54x times.
The Remus Pharmaceuticals IPO allotment status is expected on or around Wednesday, May 24, 2023. Visit Remus Pharmaceuticals IPO allotment status to check.
The Remus Pharmaceuticals IPO listing date is May 29, 2023. The equity share of Remus Pharmaceuticals IPO will list on NSE SME.
Visit Remus Pharmaceuticals IPO subscription status page for real-time bidding information about Remus Pharmaceuticals IPO.
| IPO opens On | Wednesday, May 17, 2023 |
| IPO Closes On | Friday, May 19, 2023 |
| Finalisation of Basis of Allotment | Wednesday, May 24, 2023 |
| Initiation of Refunds | Thursday, May 25, 2023 |
| Credit of Shares to Demat Account | Friday, May 26, 2023 |
| IPO Listing Date | Monday, May 29, 2023 |
| IPO Details |
| IPO Recommendations |
| IPO Live Subscription |
| IPO FAQs |
